Not FDA-approved
Hormones & metabolism
MOTS-c
Evidence
Mostly animal studies
Class
Mitochondria-derived peptide
KEY TAKEAWAY
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. In mice it improved insulin sensitivity and protected against diet-induced obesity. Human data are early and it is not approved.
Written by the Veylo editorial team · Updated
November 2026
What it is
A peptide made by mitochondria that influences metabolism
Studied for
Insulin sensitivity, exercise capacity and healthy aging
Key fact
Improved glucose handling and exercise performance in mice; human data are very early
Route
Injection (research use)
Evidence strength
Mostly animal studies
MOTS-c is a mitochondrial-derived peptide. Natural levels rise with exercise and fall with age.
In animal studies it activates the AMPK energy-sensing pathway and helps cells use glucose and fat more efficiently.
MOTS-c is not approved by the FDA. A related compound has been in early clinical development.
Studied for metabolic disease, obesity and age-related decline. It has no approved medical use.
Human safety information is limited to small early studies. Long-term effects are unknown.
Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443-454.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.